- Home
- PRTA vs FPH Comparison
PRTA vs FPH Comparison
Compare PRTA & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- FPH
- Stock Information
- Founded
- PRTA 2012
- FPH 2009
- Country
- PRTA Ireland
- FPH United States
- Employees
- PRTA N/A
- FPH N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- FPH Real Estate
- Sector
- PRTA Health Care
- FPH Finance
- Exchange
- PRTA Nasdaq
- FPH Nasdaq
- Market Cap
- PRTA 472.1M
- FPH 390.0M
- IPO Year
- PRTA N/A
- FPH 2017
- Fundamental
- Price
- PRTA $8.20
- FPH $5.68
- Analyst Decision
- PRTA Buy
- FPH
- Analyst Count
- PRTA 10
- FPH 0
- Target Price
- PRTA $14.86
- FPH N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- FPH 150.3K
- Earning Date
- PRTA 08-04-2025
- FPH 10-16-2025
- Dividend Yield
- PRTA N/A
- FPH N/A
- EPS Growth
- PRTA N/A
- FPH 46.82
- EPS
- PRTA N/A
- FPH 1.08
- Revenue
- PRTA $10,341,000.00
- FPH $197,429,000.00
- Revenue This Year
- PRTA N/A
- FPH N/A
- Revenue Next Year
- PRTA $389.77
- FPH N/A
- P/E Ratio
- PRTA N/A
- FPH $5.28
- Revenue Growth
- PRTA N/A
- FPH N/A
- 52 Week Low
- PRTA $4.32
- FPH $3.10
- 52 Week High
- PRTA $22.83
- FPH $6.71
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- FPH 56.60
- Support Level
- PRTA $8.05
- FPH $5.51
- Resistance Level
- PRTA $8.73
- FPH $5.77
- Average True Range (ATR)
- PRTA 0.38
- FPH 0.14
- MACD
- PRTA -0.05
- FPH 0.04
- Stochastic Oscillator
- PRTA 47.62
- FPH 95.83
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.